Quarterly report · Q1

Period2023-04-01 → 2023-06-30
Filed2023-08-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
MetricValuePeriodScopeSource row
Revenue¥309m2023-04-01 → 2023-06-30Cons.Net sales
Revenue¥2.4bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥361m2022-04-01 → 2022-06-30Cons.Net sales
Operating income−¥28m2023-04-01 → 2023-06-30Cons.Operating income
Operating income−¥38m2022-04-01 → 2022-06-30Cons.Operating income
Ordinary income−¥14m2023-04-01 → 2023-06-30Cons.Ordinary income
Ordinary income¥333m2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income−¥26m2022-04-01 → 2022-06-30Cons.Ordinary income
Profit before tax−¥14m2023-04-01 → 2023-06-30Cons.Income before income taxes
Profit before tax−¥26m2022-04-01 → 2022-06-30Cons.Income before income taxes
Net income (owners)−¥11m2023-04-01 → 2023-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥243m2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥19m2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income−¥11m2023-04-01 → 2023-06-30Cons.Profit loss
Net income−¥19m2022-04-01 → 2022-06-30Cons.Profit loss
Total assets¥4.3bnat 2023-06-30Cons.Assets
Total assets¥4.5bnat 2023-03-31Cons.Assets
Total assets¥4.3bnat 2022-06-30Cons.Total assets (5-year summary)
Total liabilities¥978mat 2023-06-30Cons.Liabilities
Total liabilities¥1.1bnat 2023-03-31Cons.Liabilities
Net assets / equity¥3.3bnat 2023-06-30Cons.Net assets
Net assets / equity¥3.4bnat 2023-03-31Cons.Net assets
Net assets / equity¥3.1bnat 2022-06-30Cons.Net assets (5-year summary)
Cash and deposits¥1.8bnat 2023-06-30Cons.Cash and deposits
Cash and deposits¥1.9bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥-7.862023-04-01 → 2023-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥177.532022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-13.872022-04-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio77.3%at 2023-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio75.6%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio73.2%at 2022-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 24
SegmentItemPeriodValue
jpcrp040300-q1r_E02021-000Healthcare Related Productsreportable segmentrevenue2023-04-01 → 2023-06-30¥90m
jpcrp040300-q1r_E02021-000Healthcare Related Productsreportable segmentrevenue external2023-04-01 → 2023-06-30¥90m
jpcrp040300-q1r_E02021-000Healthcare Related Productsreportable segmentsegment profit2023-04-01 → 2023-06-30¥5m
jpcrp040300-q1r_E02021-000Optical Applications And Special Customized Productsreportable segmentrevenue2023-04-01 → 2023-06-30¥143m
jpcrp040300-q1r_E02021-000Optical Applications And Special Customized Productsreportable segmentrevenue external2023-04-01 → 2023-06-30¥143m
jpcrp040300-q1r_E02021-000Optical Applications And Special Customized Productsreportable segmentsegment profit2023-04-01 → 2023-06-30¥39m
jpcrp040300-q1r_E02021-000X Ray Residual Stress Analyzerreportable segmentrevenue2023-04-01 → 2023-06-30¥76m
jpcrp040300-q1r_E02021-000X Ray Residual Stress Analyzerreportable segmentrevenue external2023-04-01 → 2023-06-30¥76m
jpcrp040300-q1r_E02021-000X Ray Residual Stress Analyzerreportable segmentsegment profit2023-04-01 → 2023-06-30¥356,000
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-06-30¥309m
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-06-30¥309m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-06-30¥45m
jpcrp040300-q1r_E02021-000Healthcare Related Productsreportable segmentrevenue2022-04-01 → 2022-06-30¥170m
jpcrp040300-q1r_E02021-000Healthcare Related Productsreportable segmentrevenue external2022-04-01 → 2022-06-30¥170m
jpcrp040300-q1r_E02021-000Healthcare Related Productsreportable segmentsegment profit2022-04-01 → 2022-06-30¥7m
jpcrp040300-q1r_E02021-000Optical Applications And Special Customized Productsreportable segmentrevenue2022-04-01 → 2022-06-30¥102m
jpcrp040300-q1r_E02021-000Optical Applications And Special Customized Productsreportable segmentrevenue external2022-04-01 → 2022-06-30¥102m
jpcrp040300-q1r_E02021-000Optical Applications And Special Customized Productsreportable segmentsegment profit2022-04-01 → 2022-06-30¥20m
jpcrp040300-q1r_E02021-000X Ray Residual Stress Analyzerreportable segmentrevenue2022-04-01 → 2022-06-30¥89m
jpcrp040300-q1r_E02021-000X Ray Residual Stress Analyzerreportable segmentrevenue external2022-04-01 → 2022-06-30¥89m
jpcrp040300-q1r_E02021-000X Ray Residual Stress Analyzerreportable segmentsegment profit2022-04-01 → 2022-06-30¥3m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-06-30¥361m
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-06-30¥361m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-06-30¥31m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 295
ItemContextValueUnit
Ordinary incomePrior1YTDDuration-26192000JPY
Ordinary incomeCurrentYTDDuration-14405000JPY
Loss on retirement of noncurrent assets elPrior1YTDDuration0JPY
Loss on retirement of noncurrent assets elCurrentYTDDuration0JPY
Extraordinary lossPrior1YTDDuration0JPY
Extraordinary lossCurrentYTDDuration0JPY
Income before income taxesPrior1YTDDuration-26192000JPY
Income before income taxesCurrentYTDDuration-14405000JPY
Income taxesPrior1YTDDuration-7209000JPY
Income taxesCurrentYTDDuration-3652000JPY
Profit lossPrior1YTDDuration-18983000JPY
Profit lossCurrentYTDDuration-10753000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration-JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration-JPY
Profit loss attributable to owners of parentPrior1YTDDuration-18983000JPY
Profit loss attributable to owners of parentCurrentYTDDuration-10753000JPY
Profit lossPrior1YTDDuration-18983000JPY
Profit lossCurrentYTDDuration-10753000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration-521000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration6924000JPY
Foreign currency translation adjustment net of tax ociPrior1YTDDuration7335000JPY
Foreign currency translation adjustment net of tax ociCurrentYTDDuration6145000JPY
Other comprehensive incomePrior1YTDDuration6813000JPY
Other comprehensive incomeCurrentYTDDuration13070000JPY
Comprehensive incomePrior1YTDDuration-12169000JPY
Comprehensive incomeCurrentYTDDuration2316000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration-12169000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration2316000JPY
Comprehensive income attributable to non controlling interestsPrior1YTDDuration-JPY
Comprehensive income attributable to non controlling interestsCurrentYTDDuration-JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q1r_E02021-000XRayResidualStressAnalyzerReportableSegmentMember89169000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q1r_E02021-000HealthcareRelatedProductsReportableSegmentMember169866000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q1r_E02021-000OpticalApplicationsAndSpecialCustomizedProductsReportableSegmentMember101976000JPY
Revenues from external customersPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember361012000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q1r_E02021-000XRayResidualStressAnalyzerReportableSegmentMember-JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q1r_E02021-000HealthcareRelatedProductsReportableSegmentMember-JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q1r_E02021-000OpticalApplicationsAndSpecialCustomizedProductsReportableSegmentMember-JPY
Transactions with other segmentsPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember-JPY
Net salesPrior1YTDDuration_jpcrp040300-q1r_E02021-000XRayResidualStressAnalyzerReportableSegmentMember89169000JPY
Net salesPrior1YTDDuration_jpcrp040300-q1r_E02021-000HealthcareRelatedProductsReportableSegmentMember169866000JPY
Net salesPrior1YTDDuration_jpcrp040300-q1r_E02021-000OpticalApplicationsAndSpecialCustomizedProductsReportableSegmentMember101976000JPY
Net salesPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember361012000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q1r_E02021-000XRayResidualStressAnalyzerReportableSegmentMember3350000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q1r_E02021-000HealthcareRelatedProductsReportableSegmentMember7426000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q1r_E02021-000OpticalApplicationsAndSpecialCustomizedProductsReportableSegmentMember20233000JPY
Operating incomePrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember31011000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q1r_E02021-000XRayResidualStressAnalyzerReportableSegmentMember75723000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q1r_E02021-000HealthcareRelatedProductsReportableSegmentMember89816000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q1r_E02021-000OpticalApplicationsAndSpecialCustomizedProductsReportableSegmentMember143475000JPY
Revenues from external customersCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember309015000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass rounding
balance sheet identityconsolidated 2023-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-06-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-06-30pass